Literature DB >> 21069519

Prescribed-drug utilization and polypharmacy in a general population in Greece: association with sociodemographic, health needs, health-services utilization, and lifestyle factors.

E Pappa1, N Kontodimopoulos, A A Papadopoulos, Y Tountas, D Niakas.   

Abstract

PURPOSE: Our aim was to analyze, in a multivariate framework, how sociodemographic, health-service utilization, health needs, and lifestyle risk factors influence drug utilization and polypharmacy (PP) in a general population in Greece.
METHODS: The cross-sectional study took place in 2006. In total 1,005 individuals (> 18 years old) of 1,388 who were approached (response rate 72.4%) were interviewed by trained interviewers. Thirty-seven reported only over-the-counter (OTC) drug use and were excluded. The final sample was 968 individuals. Multivariable logistic regression and multinomial regression analyses were conducted to determine the predictors of drug use and PP at a significance level of p < 0.05.
RESULTS: The results revealed a high rate of drug use and PP. Drug use and PP were more common among women and increased with age. Advanced age 65+ [odds ratio (OR) 11.6), university education (OR 2.3), visits to physician (OR 2.2), comorbidity (OR 6.8), or poor physical and mental health were associated with higher likelihood of using drugs. Minor (two to three drugs) and major (four or more drugs) PP depended on comorbidity, physical health, and increased age. Furthermore, visits to physicians (OR 1.1), smoking (OR 3.0), and obesity (OR 3.8) increased the likelihood of major PP.
CONCLUSIONS: Overall, drug utilization and PP depended on health needs followed by education, utilization of health services, and age. Social disparities do persist and, after adjustments for health needs and obesity, had a significant influence on PP.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21069519     DOI: 10.1007/s00228-010-0940-0

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  34 in total

1.  Income related inequality in prescription drugs in Denmark.

Authors:  Jens Gundgaard
Journal:  Pharmacoepidemiol Drug Saf       Date:  2005-05       Impact factor: 2.890

2.  Adverse drug reactions as a cause of hospital admissions: a 6-month experience in a single center in Greece.

Authors:  Alexandra Alexopoulou; Spyros P Dourakis; Demosthenes Mantzoukis; Thomas Pitsariotis; Anna Kandyli; Melanie Deutsch; Athanasios J Archimandritis
Journal:  Eur J Intern Med       Date:  2008-03-11       Impact factor: 4.487

3.  The development of polypharmacy. A longitudinal study.

Authors:  L Veehof; R Stewart; F Haaijer-Ruskamp; B M Jong
Journal:  Fam Pract       Date:  2000-06       Impact factor: 2.267

4.  Drug utilization and health behaviours among indigent elderly patients in Crete, Greece.

Authors:  L Tzimis; A Kafatos
Journal:  Pharmacoepidemiol Drug Saf       Date:  1999-03       Impact factor: 2.890

5.  Patterns of medicine use in a general population (0-80 years). The Influence of age, gender, diseases and place of residence on drug use in Norway.

Authors:  A E Eggen
Journal:  Pharmacoepidemiol Drug Saf       Date:  1997-05       Impact factor: 2.890

6.  Analysis of the association between polypharmacy and socioeconomic position among elderly aged > or =77 years in Sweden.

Authors:  Syed Imran Haider; Kristina Johnell; Mats Thorslund; Johan Fastbom
Journal:  Clin Ther       Date:  2008-02       Impact factor: 3.393

7.  The influence of educational level on polypharmacy and inappropriate drug use: a register-based study of more than 600,000 older people.

Authors:  Syed Imran Haider; Kristina Johnell; Gunilla Ringbäck Weitoft; Mats Thorslund; Johan Fastbom
Journal:  J Am Geriatr Soc       Date:  2008-11-14       Impact factor: 5.562

8.  Identifying how age and gender influence prescription drug use in a primary health care environment in Catalonia, Spain.

Authors:  Eladio Fernández-Liz; Pilar Modamio; Arantxa Catalán; Cecilia F Lastra; Teresa Rodríguez; Eduardo L Mariño
Journal:  Br J Clin Pharmacol       Date:  2007-10-08       Impact factor: 4.335

9.  Importance of patient pressure and perceived pressure and perceived medical need for investigations, referral, and prescribing in primary care: nested observational study.

Authors:  Paul Little; Martina Dorward; Greg Warner; Katharine Stephens; Jane Senior; Michael Moore
Journal:  BMJ       Date:  2004-02-13

10.  Gender influence in the quantity of drugs used in primary care.

Authors:  José Sanfélix; Vicente Palop; Inmaculada Pereiró; Elena Rubio; Victoria Gosalbes; Inocencia Martínez-Mir
Journal:  Gac Sanit       Date:  2008 Jan-Feb       Impact factor: 2.139

View more
  15 in total

1.  Determinants of change in polypharmacy status in Switzerland: the population-based CoLaus study.

Authors:  Nazanin Abolhassani; Julien Castioni; Pedro Marques-Vidal; Peter Vollenweider; Gérard Waeber
Journal:  Eur J Clin Pharmacol       Date:  2017-06-21       Impact factor: 2.953

2.  Characteristics and drug utilization patterns for heavy users of prescription drugs among the elderly: a Danish register-based drug utilization study.

Authors:  Anita Øymoen; Anton Pottegård; Anna Birna Almarsdóttir
Journal:  Eur J Clin Pharmacol       Date:  2015-04-28       Impact factor: 2.953

3.  Socio-economic and behavioral determinants of prescription and non-prescription medicine use: the case of Turkey.

Authors:  Selcen Öztürk; Dilek Başar; İlhan Can Özen; Arbay Özden Çiftçi
Journal:  Daru       Date:  2019-11-16       Impact factor: 3.117

4.  Polypharmacy in Patients with Ovarian Cancer.

Authors:  Sean Oldak; Stephanie Ioannou; Priyanka Kamath; Marilyn Huang; Sophia George; Brian Slomovitz; Matthew Schlumbrecht
Journal:  Oncologist       Date:  2019-04-05

5.  High-Cost Users of Prescription Drugs: National Health Insurance Data from South Korea.

Authors:  Dahye Park; HyeYeong Lee; Dong-Sook Kim
Journal:  J Gen Intern Med       Date:  2021-10-26       Impact factor: 6.473

6.  Cost-Sharing Rates Increase During Deep Recession: Preliminary Data From Greece.

Authors:  Athanasios Gouvalas; Michael Igoumenidis; Mamas Theodorou; Kostas Athanasakis
Journal:  Int J Health Policy Manag       Date:  2016-05-28

7.  Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study.

Authors:  Julien Castioni; Pedro Marques-Vidal; Nazanin Abolhassani; Peter Vollenweider; Gérard Waeber
Journal:  BMC Health Serv Res       Date:  2017-12-21       Impact factor: 2.655

8.  Drug utilization patterns among elderly hospitalized patients on poly-pharmacy in Punjab, Pakistan.

Authors:  Muhammad Rehan Sarwar; Muhammad Atif; Shane Scahill; Anum Saqib; Muhammad Qamar-Uz-Zaman; Zaheer Babar
Journal:  J Pharm Policy Pract       Date:  2017-08-04

9.  Factors associated with excessive polypharmacy in older people.

Authors:  Denise Walckiers; Johan Van der Heyden; Jean Tafforeau
Journal:  Arch Public Health       Date:  2015-11-09

10.  Investigation of social, demographic and health variations in the usage of prescribed and over-the-counter medicines within a large cohort (South Yorkshire, UK).

Authors:  Mark A Green; Emma Little; Richard Cooper; Clare Relton; Mark Strong
Journal:  BMJ Open       Date:  2016-09-28       Impact factor: 2.692

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.